FORBES: Drug Prices Keep Rising Amid Political Pressure, But Not As Fast

Prices for the majority of drugs in the U.S. have started to rise more slowly, likely a result of public and political pressure.

Big Pharma’s image sinks to new low amid opioid crisis, high drug prices

The pharmaceutical industry has outdone itself. It is now the most widely hated industry in the US, unseating the federal government as the lowest of the low, according to a new Gallup poll.

THE HILL: Don’t miss the moment: Congress must capitalize on momentum to hold Big Pharma accountable

The American people are demanding that Congress hold Big Pharma accountable and the momentum to lower prescription drug prices has never been greater.

WSHU PUBLIC RADIO: Blumenthal Bill Targets Pharma’s Manipulation Of Patent System

U.S. Senator Richard Blumenthal of Connecticut introduced legislation that he hopes will bring down the high cost of prescription drugs.

ARS TECHNICA: 879% drug price hike is one of 3,400 in 2019 so far; rate of hikes increasing

Despite public and political pressure, pharma keeps on ratcheting up prices.

POLITICO: Drug prices persistently rising despite Trump efforts

Prescription drug prices jumped 10.5 percent over the past six months, more slowly than during the same period last year but still four times faster than inflation.

CBS NEWS: Drug prices in 2019 are surging, with hikes at 5 times inflation

Price hikes on prescription drugs are surging in 2019, despite vows from lawmakers and the Trump administration to rein in pharmaceutical costs.

OPEN SECRETS: Efforts to reduce drug prices stall amid pharmaceutical lobbying

Prescription drug prices are too high — there is a bipartisan consensus on that much in Washington, as recent estimates suggest that the average American spends about $1,200 on prescription drugs each year.

THE WEEK: Just how did insulin get so expensive?

How on earth did insulin become so expensive that Americans are forced to effectively do cross-border drug runs?

FIERCEHEALTHCARE: Prices for top-selling drugs appear immune to common market forces: study

When it comes to concerns over the rising costs of prescription drugs, it’s not just an isolated few that should be grabbing the headlines.